CritiView is a adjunctive bedside patient monitoring device to be
applied in intensive care, operating suits and emergency care settings,
||Early identification / warning of the body’s critical
metabolic imbalances or tissue viability of a patient;
||A sensitive tissue based therapy titration monitor and as
end point of resuscitation.
Critically ill patients in variety of disease entities such as
sepsis, develop during the course of their illnesses episodes of
shock or a relative reduction in oxygen delivery to various organs.
The assessment of degree of perfusion and adequacy of oxygen delivery
to tissues and organs is critical for the management of the patient
and in the evaluation of the patients' status, prognosis and response
CritiView allows a non-invasive assessment in non-vital tissue
of the metabolic activity and the energy state of the mitochondria,
as well as information regarding the microcirculation. This real-time
information enables the physician to evaluate whether the patient
is in shock, whether the shock state is worsening and what is the
effectiveness of the response to therapy with fluids or drugs. CritiView
will provide useful, sensitive and specific information on the metabolic
status of the patient, adding significant information to current
procedures and improving the state-of-the-art in patient monitoring
in critical care.
The CritiView tissue viability monitoring systems consist of a
disposable urethral wall probe integrated into a Foley urinary catheter
and a free-standing base unit containing light sources, signal detectors,
processing units and a display.
Oxygen Gradient from
Air to Mitochondria &
Monitoring Parameters / Modalities